PMC:7346000 / 1236-1514
Annnotations
LitCovid-PubTator
{"project":"LitCovid-PubTator","denotations":[{"id":"27","span":{"begin":175,"end":185},"obj":"Species"},{"id":"30","span":{"begin":132,"end":138},"obj":"Chemical"},{"id":"31","span":{"begin":228,"end":242},"obj":"Chemical"},{"id":"32","span":{"begin":272,"end":277},"obj":"Chemical"},{"id":"45","span":{"begin":140,"end":153},"obj":"Disease"}],"attributes":[{"id":"A27","pred":"tao:has_database_id","subj":"27","obj":"Tax:2697049"},{"id":"A30","pred":"tao:has_database_id","subj":"30","obj":"MESH:D001393"},{"id":"A31","pred":"tao:has_database_id","subj":"31","obj":"MESH:D000666"},{"id":"A32","pred":"tao:has_database_id","subj":"32","obj":"MESH:D001393"},{"id":"A45","pred":"tao:has_database_id","subj":"45","obj":"MESH:D007674"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"n of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-"}
LitCovid-PD-MONDO
{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T19","span":{"begin":23,"end":27},"obj":"Disease"},{"id":"T20","span":{"begin":55,"end":59},"obj":"Disease"},{"id":"T21","span":{"begin":175,"end":183},"obj":"Disease"}],"attributes":[{"id":"A19","pred":"mondo_id","subj":"T19","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A20","pred":"mondo_id","subj":"T20","obj":"http://purl.obolibrary.org/obo/MONDO_0007163"},{"id":"A21","pred":"mondo_id","subj":"T21","obj":"http://purl.obolibrary.org/obo/MONDO_0005091"}],"text":"n of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T8","span":{"begin":241,"end":242},"obj":"http://purl.obolibrary.org/obo/CLO_0001021"}],"text":"n of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-"}
LitCovid-PD-CHEBI
{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":78,"end":82},"obj":"Chemical"},{"id":"T4","span":{"begin":83,"end":87},"obj":"Chemical"},{"id":"T5","span":{"begin":132,"end":138},"obj":"Chemical"},{"id":"T6","span":{"begin":228,"end":242},"obj":"Chemical"},{"id":"T7","span":{"begin":272,"end":277},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A4","pred":"chebi_id","subj":"T4","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A5","pred":"chebi_id","subj":"T5","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"},{"id":"A6","pred":"chebi_id","subj":"T6","obj":"http://purl.obolibrary.org/obo/CHEBI_2682"},{"id":"A7","pred":"chebi_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/CHEBI_68452"}],"text":"n of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-"}
LitCovid-PD-GO-BP
{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T2","span":{"begin":146,"end":153},"obj":"http://purl.obolibrary.org/obo/GO_0009606"}],"text":"n of the prevalence of CAPA. Finally, the treatment of CAPA is complicated by drug–drug interactions associated with broad spectrum azoles, renal tropism and damage caused by SARS-CoV-2, which may challenge the use of liposomal amphotericin B, as well as the emergence of azole-"}